title: Further evaluation of Vigabatrin therapy in 4-hydroxybutyric aciduria.
authors.forename: C
authors.initials: C
authors.lastname: Jakobs
authors.forename: T
authors.initials: T
authors.lastname: Michael
authors.forename: E
authors.initials: E
authors.lastname: Jaeger
authors.forename: J
authors.initials: J
authors.lastname: Jaeken
authors.forename: K M
authors.initials: KM
authors.lastname: Gibson
mesh_terms: D000612:4-Aminobutyrate Transaminase / Q000037:antagonists & inhibitors*; D000445:Aldehyde Oxidoreductases / Q000172:deficiency*; D000592:Amino Acid Metabolism, Inborn Errors / Q000188:drug therapy*; D000614:Aminocaproates / Q000627:therapeutic use*; D002648:Child; D005260:Female; D006801:Humans; D012978:Sodium Oxybate / Q000652:urine; D050644:Succinate-Semialdehyde Dehydrogenase; D020888:Vigabatrin
chemical_list: D000614:Aminocaproates; D012978:Sodium Oxybate; D000445:Aldehyde Oxidoreductases; C493643:ALDH5A1 protein, human; D050644:Succinate-Semialdehyde Dehydrogenase; D000612:4-Aminobutyrate Transaminase; D020888:Vigabatrin